tm
Seeing Is Believing
tm
Seeing Is Believing
CinCor Pharma's activity chart (see below) currently has 14 price targets and 15 ratings on display.
Analysts average stock forecasts to be materialized ratio is 46.3% with an average time for these price targets to be met of 56.44 days.
Most recent stock forecast was given by from BARCLAYS on 12-Jan-2023. First documented stock forecast 01-Feb-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Dec-2022
$31
$1.94 (6.68%)
3 years 9 months 2 days ago
(12-Jan-2023)
1/2 (50%)
$1.93 (6.64%)
33
Hold Since 29-Nov-2022
$30
$0.94 (3.23%)
3 years 9 months 4 days ago
(10-Jan-2023)
2/3 (66.67%)
$1.2 (4.17%)
24
Buy Since 01-Feb-2022
$50
$20.94 (72.06%)
$30
3 years 10 months 14 days ago
(30-Nov-2022)
1/2 (50%)
$38.2 (323.73%)
188
Buy Since 01-Feb-2022
$60
3 years 10 months 15 days ago
(29-Nov-2022)
2/3 (66.67%)
$25 (71.43%)
103
Buy Since 22-Aug-2022
$53
$23.94 (82.38%)
$73
3 years 10 months 16 days ago
(28-Nov-2022)
0/2 (0%)
$38.89 (275.62%)
What is CINC (CinCor Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on CINC (CinCor Pharma)?
Which analyst has the current lower performing score on CINC (CinCor Pharma) with a proven track record?
Which analyst has the most public recommendations on CINC (CinCor Pharma)?
Which analyst is the currently most bullish on CINC (CinCor Pharma)?
Which analyst is the currently most reserved on CINC (CinCor Pharma)?
